Award
NIH Reporter #1R01HL181640-01A1
Mechanisms of Sex-specific responses to obstructive sleep apnea Therapies (MoST)
Recipient
New York University School of Medicine
Award Amount
$795,421.00
Ceiling
$795,421.00
Awarded
August 31, 2026
Identifier
1R01HL181640-01A1
NYU School of Medicine received NIH funding for a clinical trial studying whether men and women respond differently to obstructive sleep apnea treatments, particularly N-acetylcysteine and positive airway pressure.
Description
A randomized crossover clinical trial examining sex-specific responses to obstructive sleep apnea therapies, including positive airway pressure and N-acetylcysteine, and their effects on vascular function and cardiovascular risk.